129 related articles for article (PubMed ID: 37105784)
21. Interventional endoscopy, neoadjuvant therapy and the gastroenterologist.
Snady H
Hematol Oncol Clin North Am; 2002 Feb; 16(1):53-79. PubMed ID: 12063829
[TBL] [Abstract][Full Text] [Related]
22. Standards and perspectives in the diagnosis and treatment of pancreatic adenocarcinoma.
Sulkowski U
Digestion; 1996; 57 Suppl 1():34-5. PubMed ID: 8813464
[TBL] [Abstract][Full Text] [Related]
23. Impact of ethnicity on outcome in pancreatic carcinoma.
Saif MW; Sviglin H; Carpenter M
JOP; 2005 May; 6(3):246-54. PubMed ID: 15883475
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic Adenocarcinoma in the Finistère Area, France, Between 2002 and 2011 (1002 Cases): Population Characteristics, Treatment and Survival.
Arnachellum RP; Cariou M; Nousbaum JB; Jezequel J; Le Reste JY; Robaszkiewicz M
Pancreas; 2016 Aug; 45(7):953-60. PubMed ID: 26765965
[TBL] [Abstract][Full Text] [Related]
25. Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma.
Lee KJ; Yi SW; Chung MJ; Park SW; Song SY; Chung JB; Park JY
Yonsei Med J; 2013 May; 54(3):643-9. PubMed ID: 23549809
[TBL] [Abstract][Full Text] [Related]
26. Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinical review of 1,082 patients.
Kuroda T; Kumagi T; Yokota T; Seike H; Nishiyama M; Imai Y; Inada N; Shibata N; Imamine S; Okada S; Koizumi M; Yamanishi H; Azemoto N; Miyaike J; Tanaka Y; Tatsukawa H; Utsunomiya H; Ohno Y; Miyake T; Hirooka M; Furukawa S; Abe M; Ikeda Y; Matsuura B; Hiasa Y; Onji M;
BMC Gastroenterol; 2013 Aug; 13():134. PubMed ID: 24256464
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases.
Falchook GS; Wolff RA; Varadhachary GR
Gynecol Oncol; 2008 Mar; 108(3):515-9. PubMed ID: 18164378
[TBL] [Abstract][Full Text] [Related]
28. Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma.
Perri G; Prakash L; Qiao W; Varadhachary GR; Wolff R; Fogelman D; Overman M; Pant S; Javle M; Koay EJ; Herman J; Kim M; Ikoma N; Tzeng CW; Lee JE; Katz MHG
Ann Surg; 2020 Jun; 271(6):996-1002. PubMed ID: 31895709
[TBL] [Abstract][Full Text] [Related]
29. Metastatic pancreatic adenocarcinoma presented as back pain in pregnancy: case report and review of literature.
Lui MW; Lai CW; Ong CY
J Matern Fetal Neonatal Med; 2016; 29(9):1421-4. PubMed ID: 26067261
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival after pancreatic adenocarcinoma--often a misdiagnosis?
Alanen KA; Joensuu H
Br J Cancer; 1993 Nov; 68(5):1004-5. PubMed ID: 8217587
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in ductal pancreatic cancer.
Yeo CJ; Cameron JL
Langenbecks Arch Surg; 1998 Apr; 383(2):129-33. PubMed ID: 9641885
[TBL] [Abstract][Full Text] [Related]
32. The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma.
Boyd CA; Benarroch-Gampel J; Sheffield KM; Han Y; Kuo YF; Riall TS
Surgery; 2012 Sep; 152(3):403-13. PubMed ID: 22938900
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer.
Shinchi H; Maemura K; Mataki Y; Kurahara H; Sakoda M; Ueno S; Hiraki Y; Nakajo M; Natsugoe S; Takao S
J Hepatobiliary Pancreat Sci; 2012 Mar; 19(2):152-8. PubMed ID: 21647560
[TBL] [Abstract][Full Text] [Related]
34. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma.
Cho M; Peddi PF; Ding K; Chen L; Thomas D; Wang J; Lockhart AC; Tan B; Wang-Gillam A
J Transl Med; 2013 Sep; 11():206. PubMed ID: 24011168
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of the Affordable Care Act on the stage at presentation and receipt of treatment for pancreatic adenocarcinoma.
Hao S; Mitsakos A; Popowicz P; Irish W; Snyder RA; Parikh AA
J Surg Oncol; 2022 Sep; 126(4):698-707. PubMed ID: 35699593
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III?
Song M; Yoon SB; Lee IS; Hong TH; Choi HJ; Choi MH; Lee MA; Jung ES; Choi MG
Eur J Cancer; 2018 Nov; 104():62-69. PubMed ID: 30326370
[TBL] [Abstract][Full Text] [Related]
38. [Pancreatic adenocarcinoma: therapeutical update].
Khosravi Shahi P; Díaz Muñoz de la Espada VM
An Med Interna; 2005 Aug; 22(8):390-4. PubMed ID: 16351494
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials.
Cubiella J; Castells A; Fondevila C; Sans M; Sabater L; Navarro S; Fernández-Cruz L
Am J Gastroenterol; 1999 May; 94(5):1271-8. PubMed ID: 10235206
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic Adenocarcinoma, Version 1.2019.
Tempero MA; Malafa MP; Chiorean EG; Czito B; Scaife C; Narang AK; Fountzilas C; Wolpin BM; Al-Hawary M; Asbun H; Behrman SW; Benson AB; Binder E; Cardin DB; Cha C; Chung V; Dillhoff M; Dotan E; Ferrone CR; Fisher G; Hardacre J; Hawkins WG; Ko AH; LoConte N; Lowy AM; Moravek C; Nakakura EK; O'Reilly EM; Obando J; Reddy S; Thayer S; Wolff RA; Burns JL; Zuccarino-Catania G
J Natl Compr Canc Netw; 2019 Mar; 17(3):202-210. PubMed ID: 30865919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
